Hydroxychloroquine for Early Treatment of Adults With Mild Coronavirus Disease 2019: A Randomized, Controlled Trial.

O, Mitjà; M, Corbacho-Monné; M, Ubals; C, Tebé; J, Peñafiel; A, Tobias; E, Ballana; A, Alemany; N, Riera-Martí; CA, Pérez; C, Suñer; P, Laporte; P, Admella; J, Mitjà; M, Clua; L, Bertran; M, Sarquella; S, Gavilán; J, Ara; JM, Argimon; J, Casabona; G, Cuatrecasas; P, Cañadas; A, Elizalde-Torrent; R, Fabregat; M, Farré; A, Forcada; G, Flores-Mateo; E, Muntada; N, Nadal; S, Narejos; A, Nieto; N, Prat; J, Puig; C, Quiñones; J, Reyes-Ureña; F, Ramírez-Viaplana; L, Ruiz; E, Riveira-Muñoz; A, Sierra; C, Velasco; RM, Vivanco-Hidalgo; A, Sentís; C, G-Beiras; B, Clotet; M, Vall-Mayans

doi:10.1093/cid/ciaa1009

Public

Hydroxychloroquine for Early Treatment of Adults With Mild Coronavirus Disease 2019: A Randomized, Controlled Trial.

Shared by NobleBlocks on Dec 1, 2021 • 12:00 AM UTC

Authors:

Mitjà O

Corbacho-Monné M

Ubals M

Abstract

Background No effective treatments for coronavirus disease 2019 (COVID-19) exist. We aimed to determine whether early treatment with hydroxychloroquine (HCQ) would be efficacious for outpatients with COVID-19.Methods Multicenter open-label, randomized, controlled trial conducted in Catalonia, Spain,...

Subject

Therapy

Randomized controlled trial

Hydroxychloroquine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!